Registration for a live webinar on 'Innovative Vaccines and Viral Pathogenesis: Insights from Recent Monkeypox (Mpox) Research' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Symptoms of depression
- Noradrenergic pathways in depression
- Serotonergic pathways in normal brain
- Serotonergic pathways in depression
- Desirable drug - effective in all types of depression
- Desirable features of a drug - rapid onset of action
- Desirable features of an antidepressant
- Psychopathology of depression and drugs used
- Amine deficiency hypothesis
- Neurotransmitters involved in depression
- Treatment and adaptive changes
- Classification of european antidepressants
- MAO inhibitors
- Reuptake inhibitors
- Nonselective reuptake inhibitors
- Selective reuptake inhibitors
- Other antidepressants
- Selectivity of transmitter uptake inhibitors
- Cross-talk between the neurotransmitters
- Sites of action of tricyclics on neuron
- Sites of action of MAO inhibitors
- Electroconvulsive shock therapy
Topics Covered
- Noradrenergic pathways in depression
- Serotonergic pathways in normal brain and in depression
- Desirable features of an antidepressant
- Drugs used in the treatment of depression
- Classification of antidepressants
- Tricyclic antidepressants and monoamine
- Oxidase inhibitors: sites of action
- The relationship between pre- and post-synaptic structures
- Electroconvulsive shock therapy
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Leonard, B. (2007, October 1). Psychopharmacology of depression [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved November 21, 2024, from https://doi.org/10.69645/ZTMM9663.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. Brian Leonard has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.